Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.

BMC nephrology - 7 Sept 2022

Jacob Jerry, Boczkowska Sylwia, Zaluska Wojciech, Buraczynska Monika

Abstract excerpt

BACKGROUND: Plasma triglyceride (TG) levels are a significant risk factor for cardiovascular disease (CVD). The APOA5 gene is one of the crucial factors in plasma TG metabolism regulation. The rs662799 polymorphism in the APOA5 gene has been reported to be associated with cardiovascular disease. The goal of this study was to evaluate the potential association of this variant with CVD in patients with end-stage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Kidney Failure, Chronic

Share to Polymorphism, Genetic

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 36071387
DOI: 10.1186/s12882-022-02925-1
PMCID: PMC9450442

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.PMID 36071387Read ↗

LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients.Semantic proximity Read ↗

Association of S19W polymorphism in APOA5 gene and serum lipid levels in patients with type 2 diabetic nephropathy.Semantic proximity Read ↗

Association of rs662799 in APOA5 with CAD in Chinese Han population.Semantic proximity Read ↗

APOA5 Variant rs662799, Role in Cardiovascular Traits and Serum Adipokine Levels in Caucasian Obese Subjects.Semantic proximity Read ↗

Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.Semantic proximity Read ↗

Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.Semantic proximity Read ↗

The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.Semantic proximity Read ↗

Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.Semantic proximity Read ↗

Apolipoprotein A5 in health and disease.Semantic proximity Read ↗

Clinical significance of apolipoprotein A5.Semantic proximity Read ↗

Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.Semantic proximity Read ↗

Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.